position: EnglishChannel > Innovation Wire > Article

China's New Drug Benefits to Anemia of Chronic Kidney Disease Patients

Source: International Union for Science and Technology Communication| 2020-04-16 12:39:59| Author: 余昊原

(Beijing,August 2)Roxadustat, a new drug used for treating anemia of chronic kidney disease, has recently been recognized by top international academia. It is expected to lead the revolutionary change in the treatment mode of renal anemia.

The Roxadustat is a "domestic I" new drug that was developed jointly by FibroGen(China) and AstraZeneca(China). It was priority approved and marketed in China, and the Chinese patient can be the first batch to be treated with the new drug in the worldwide. It will bring benefits to 120 million Chinese patients who are suffering from Chronic Kidney Disease. 

Roxadustat can effectively treat and maintain the hemoglobin level for dialysis patients with chronic renal anemia. Before it enters the market, no novel target drug has been developed successfully in the field of renal anemia for nearly 30 years.

Renal anemia is one of the common complications of chronic kidney disease, in which the patient has an unusually low count of red blood cells. 98.2 percent of the dialysis patients have the complication, and the anemia treatment rate of dialysis patients is only 21.3%.

Poor control of the renal anemia will increase the risk of Cardiovascular disease incidence and death among dialysis patients. The symptom can not only affect the patients' physical health, mental health, and social function but also bring a heavy economic burden to their families and even the whole society. 

"It is China firstly debuted the Roxasta capsules in the market. China has become one of the first countries in the world to priority create a mechanism of action drug," said an official from China Food and Drug Administration.


Top News

  • Wirelessly charging your phone through the smart clothes you wear is a scenario that may sound like science fiction, but is gradually becoming a reality. This is one of the research projects of a team headed by Peng Huisheng, director of the Department of Macromolecular Science, Fudan University.

Gather Youth's Power, Embrace Int'l Cooperation

Tanaporn Khotphat, deputy director of the Institute of Thai Studies at the International College of Guangxi University, believes young researchers from China and Thailand will play a critical part in future joint academic activities. "I hope China and Thailand could benefit from win -win cooperation and common development. Chinese and Thai people are as close as one family, " said Khotphat,who was giving the keynote speech at the 3rd ASEAN Plus Three (10+3) Young Scientists Forum in Nanning, Guangxi Zhuang Autonomous Region.

China was in the front line of the epidemic and made key contributions to the scientific community

China held a ceremony in Beijing for honoring people fighting COVID-19 with national medals on September 8. To know more about the international reactions, Science and Technology Daily Reporter Zhang Jiaxing interviewed Dr. Lawrence Banks and Dr. Alessandro Marcello from International Centre Engineering and Biotechnology.

Copyright © Science and Technology Daily, All Rights Reserved

mailto: yuhy@stdaily.com